Healthcare Industry News: HSMN NewsFeed
News Release - September 27, 2011
BIOTRONIK Selectra Lead Introducer System Gets Strong Reviews in First CasesLAKE OSWEGO, Ore. & BERLIN--(Healthcare Sales & Marketing Network)-- The BIOTRONIK Selectra CS Lead Introducer System has received overwhelmingly positive reviews in the first device implantation cases across the US and Europe. Physicians are unanimous that Selectra delivers a significant advancement in lead placement systems for cardiac resynchronization therapy (CRT) devices.
Ishu Rao, M.D., clinical cardiac electrophysiologist (EP) with Cardiology Associates Medical Group in Ventura, California, comments, "Selectra demonstrates that BIOTRONIK is responsive to the needs of electrophysiologists – they understood the problems we face in these delicate and demanding procedures and developed a tool set that makes a difference.”
Selectra’s streamlined hub with a fully integrated hemostatic valve minimizes handling complexity and maximizes the working length of the sheath during implant. The hydrophilic inner coating and low-friction valve are designed to reduce resistance and facilitate maneuverability of the lead.
“The Selectra system provides the right amount of flexibility, torqueability and visibility to easily access the coronary sinus”, describes Craig McCotter, M.D., director of the Upstate Atrial Fibrillation and Arrhythmia Center in Greenville, South Carolina, USA. “The design of the hub with an integrated slittable valve is made for ease of use, and lowers concerns for lead dislodgement as the sheath is removed."
Physicians who provided feedback to the company did so after using Selectra in multiple patient procedures, of which many were described as “difficult anatomy”. EPs consistently gave Selectra very high marks for performance, most often citing “secure lead placement” and “ease of use”.
The Selectra lead introducer system complements BIOTRONIK’s broad CRT portfolio, which includes Corox BP leads and premium Lumax CRT-D devices. This new entry follows the January 2011 launch of the Corox OTW-L BP left ventricular lead, a third unique design with excellent stability and handling characteristics.
About BIOTRONIK SE & Co. KG
As one of the world’s leading manufacturers of cardiovascular medical devices, with several million devices implanted, BIOTRONIK is represented in over 100 countries by its global workforce of over 5,600 employees. Known for having its finger on the pulse of the medical community, BIOTRONIK assesses the challenges physicians face, and provides the best solutions for all phases of patient care, ranging from diagnosis to treatment to patient management. Quality, innovation and reliability define BIOTRONIK and its growing success, and deliver confidence and peace of mind to physicians and their patients worldwide.
More information: www.biotronik.com
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsESC Congress 2017: BIOTRONIK's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial
Getinge announces full U.S. availability of Pulsar(R)-18 self-expanding stent from BIOTRONIK for patients with peripheral artery disease
BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker